Taken together, expression of RHAMM is a valuable prognostic factor of lung adenocarcinoma, and our findings suggest that RHAMM, most likely RHAMMB, is a potential therapeutic target for preventing metastatic NSCLC. The gene discussed is HMMR; the disease is lung adenocarcinoma.